Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt No Debt
MBLX's Cash to Debt is ranked higher than
99% of the 1036 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.38 vs. MBLX: No Debt )
MBLX' s 10-Year Cash to Debt Range
Min: 9.28   Max: No Debt
Current: No Debt

Equity to Asset 0.60
MBLX's Equity to Asset is ranked higher than
72% of the 1029 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.52 vs. MBLX: 0.60 )
MBLX' s 10-Year Equity to Asset Range
Min: -6.36   Max: 0.95
Current: 0.6

-6.36
0.95
Interest Coverage No Debt
MBLX's Interest Coverage is ranked higher than
92% of the 693 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 21.51 vs. MBLX: No Debt )
MBLX' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 3
Z-Score: -37.98
M-Score: -3.14
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -784.66
MBLX's Operating margin (%) is ranked lower than
66% of the 1039 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.84 vs. MBLX: -784.66 )
MBLX' s 10-Year Operating margin (%) Range
Min: -8691.74   Max: 8.51
Current: -784.66

-8691.74
8.51
Net-margin (%) -784.86
MBLX's Net-margin (%) is ranked lower than
66% of the 1039 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.80 vs. MBLX: -784.86 )
MBLX' s 10-Year Net-margin (%) Range
Min: -8661.38   Max: 8.58
Current: -784.86

-8661.38
8.58
ROE (%) -151.15
MBLX's ROE (%) is ranked lower than
66% of the 1028 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.00 vs. MBLX: -151.15 )
MBLX' s 10-Year ROE (%) Range
Min: -122.86   Max: 8.36
Current: -151.15

-122.86
8.36
ROA (%) -123.34
MBLX's ROA (%) is ranked lower than
66% of the 1040 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.73 vs. MBLX: -123.34 )
MBLX' s 10-Year ROA (%) Range
Min: -518.55   Max: 5.32
Current: -123.34

-518.55
5.32
ROC (Joel Greenblatt) (%) -1934.23
MBLX's ROC (Joel Greenblatt) (%) is ranked lower than
67% of the 1039 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.33 vs. MBLX: -1934.23 )
MBLX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2836.08   Max: 198.29
Current: -1934.23

-2836.08
198.29
Revenue Growth (%) 100.00
MBLX's Revenue Growth (%) is ranked higher than
99% of the 892 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.50 vs. MBLX: 100.00 )
MBLX' s 10-Year Revenue Growth (%) Range
Min: -58.5   Max: 173.7
Current: 100

-58.5
173.7
EBITDA Growth (%) -14.80
MBLX's EBITDA Growth (%) is ranked higher than
50% of the 813 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.60 vs. MBLX: -14.80 )
MBLX' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 4.5
Current: -14.8

0
4.5
EPS Growth (%) -15.30
MBLX's EPS Growth (%) is ranked higher than
55% of the 751 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. MBLX: -15.30 )
MBLX' s 10-Year EPS Growth (%) Range
Min: -18.2   Max: 4.5
Current: -15.3

-18.2
4.5
» MBLX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MBLX Guru Trades in Q3 2013

Jim Simons 50,115 sh (-21.33%)
» More
Q4 2013

MBLX Guru Trades in Q4 2013

Jim Simons 67,500 sh (+34.69%)
» More
Q1 2014

MBLX Guru Trades in Q1 2014

Jim Simons 51,900 sh (-23.11%)
» More
Q2 2014

MBLX Guru Trades in Q2 2014

Jim Simons 56,507 sh (+8.88%)
» More
» Details

Insider Trades

Latest Guru Trades with MBLX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 3.75
MBLX's P/B is ranked lower than
60% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.67 vs. MBLX: 3.75 )
MBLX' s 10-Year P/B Range
Min: 0.69   Max: 18.75
Current: 3.75

0.69
18.75
P/S 6.82
MBLX's P/S is ranked lower than
70% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.00 vs. MBLX: 6.82 )
MBLX' s 10-Year P/S Range
Min: 0.93   Max: 1069
Current: 6.82

0.93
1069
EV-to-EBIT -0.66
MBLX's EV-to-EBIT is ranked lower than
59% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.54 vs. MBLX: -0.66 )
MBLX' s 10-Year EV-to-EBIT Range
Min: -114.7   Max: 18.4
Current: -0.66

-114.7
18.4
Current Ratio 2.32
MBLX's Current Ratio is ranked higher than
79% of the 1037 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.75 vs. MBLX: 2.32 )
MBLX' s 10-Year Current Ratio Range
Min: 1.43   Max: 38.31
Current: 2.32

1.43
38.31
Quick Ratio 1.59
MBLX's Quick Ratio is ranked higher than
79% of the 1037 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.20 vs. MBLX: 1.59 )
MBLX' s 10-Year Quick Ratio Range
Min: 1.43   Max: 38.31
Current: 1.59

1.43
38.31

Valuation & Return

vs
industry
vs
history
Price/Net Cash 25.00
MBLX's Price/Net Cash is ranked higher than
95% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. MBLX: 25.00 )
MBLX' s 10-Year Price/Net Cash Range
Min: 1.34   Max: 27.66
Current: 25

1.34
27.66
Price/Net Current Asset Value 8.33
MBLX's Price/Net Current Asset Value is ranked higher than
93% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9999.00 vs. MBLX: 8.33 )
MBLX' s 10-Year Price/Net Current Asset Value Range
Min: 1.28   Max: 27.66
Current: 8.33

1.28
27.66
Price/Tangible Book 3.75
MBLX's Price/Tangible Book is ranked higher than
55% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.13 vs. MBLX: 3.75 )
MBLX' s 10-Year Price/Tangible Book Range
Min: 1.01   Max: 18.44
Current: 3.75

1.01
18.44
Price/Median PS Value 0.06
MBLX's Price/Median PS Value is ranked higher than
100% of the 1069 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.10 vs. MBLX: 0.06 )
MBLX' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 9.89
Current: 0.06

0.01
9.89
Earnings Yield (Greenblatt) -151.50
MBLX's Earnings Yield (Greenblatt) is ranked lower than
87% of the 876 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.90 vs. MBLX: -151.50 )
MBLX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.4   Max: 760.5
Current: -151.5

5.4
760.5
Forward Rate of Return (Yacktman) -116.44
MBLX's Forward Rate of Return (Yacktman) is ranked lower than
62% of the 825 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.92 vs. MBLX: -116.44 )
MBLX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -243.7   Max: -11.8
Current: -116.44

-243.7
-11.8

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:M6X.Germany
Metabolix, Inc. was incorporated in Massachusetts in June 1992 under the name Metabolix, Inc. In September 1998, it reincorporated in Delaware. The Company is a bioscience company focused on bringing environmentally friendly solutions to the plastics, chemicals and energy industries. It has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. In addition, it has created an intellectual property portfolio to protect its innovations. The Company has focused on a family of biopolymers found in nature called polyhydroxyalkanoates, or ('PHAs'), which occur naturally in living organisms and are chemically similar to polyesters. It has demonstrated the production of PHAs at the industrial scale to produce PHA biopolymers and biobased industrial chemicals, as well as production of PHB, a subclass of PHA biopolymer, in agriculturally significant crop plants. The Company's biopolymers, marketed under the Mirel and Mvera brands. Its third technology platform, crop-based businesses, which is at an early stage, is a biorefinery system, which uses plant crops to co-produce PHAs that can be recovered as bioplastics or converted to biobased chemicals while also generating bioenergy or biofuels in an integrated biorefinery. The Company is conducting research to develop genetically modified, camelina for co-production of bioplastics along with vegetable oil, biodiesel fuel and oleochemicals. The Company is engineering switchgrass to produce bioplastics in the leaf and stem of the plant. Switchgrass is a commercially and ecologically attractive, non-food energy crop that is indigenous to North America. The Company's main competitors include Dow Chemical, DuPont, BASF, Ineos, LyondellBasell, SABIC, Mitsubishi Chemical, Arkema, Braskem, Kaneka, Tianan, Tianjin, EcoMann, NatureWorks, Mitsui Chemical, Teijin, Novamont and Biome. The Company is subject to significant foreign and domestic government regulations.
» More Articles for MBLX

Headlines

Articles On GuruFocus.com
5 Biggest Losers of Magic Formula Investing in 2013 Dec 18 2013 
comment on MBLX Sep 25 2012 
comment on MBLX Aug 07 2012 
METABOLIX, INC. Reports Operating Results (10-K) Mar 10 2011 
Market Neutral Trade for 2.10.2011: Long EMN, Short MBLX Feb 10 2011 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 09 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Jul 29 2010 
METABOLIX, INC. Reports Operating Results (10-Q) May 03 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 03 2009 
METABOLIX, INC. Reports Operating Results (10-Q) Aug 06 2009 

More From Other Websites
Nasdaq stocks posting largest volume increases Oct 24 2014
METABOLIX, INC. Files SEC form 8-K, Other Events Oct 21 2014
Metabolix to Conduct Webcast of Its Third Quarter Fiscal Year 2014 Earnings Call Oct 21 2014
Metabolix to Conduct Webcast of Its Third Quarter Fiscal Year 2014 Earnings Call Oct 21 2014
Metabolix to Present Data Showing That Biobased PHA Copolymers Deliver Key Performance Improvements... Oct 20 2014
Metabolix to Present Data Showing That Biobased PHA Copolymers Deliver Key Performance Improvements... Oct 20 2014
METABOLIX, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Material... Oct 06 2014
METABOLIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and... Aug 25 2014
Metabolix, Inc. Closes $25 Million Private Placement Aug 25 2014
METABOLIX, INC. Financials Aug 19 2014
METABOLIX, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and... Aug 11 2014
Metabolix Granted Financial Viability Exception By NASDAQ Aug 11 2014
METABOLIX, INC. Files SEC form 10-Q, Quarterly Report Aug 08 2014
METABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 06 2014
Metabolix Announces Second Quarter 2014 Financial Results Aug 06 2014
METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Aug 04 2014
Metabolix, Inc. Enters into Private Placement Agreement with Investors to Raise $25 Million in... Aug 04 2014
Metabolix to Conduct Webcast of Its Second Quarter Fiscal Year 2014 Earnings Call Aug 04 2014
3 Stocks Pushing The Chemicals Industry Lower Jul 25 2014
3 Stocks Pushing The Chemicals Industry Lower Jul 17 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK